造血干细胞移植后肾损伤的研究进展
Research Progress of Kidney Injury after Hematopoietic Stem Cell Transplantation in Children
DOI: 10.12677/acm.2025.1551533, PDF,   
作者: 张静茹*, 窦 颖#：重庆医科大学附属儿童医院血液肿瘤科，国家儿童健康与疾病临床医学研究中心，儿童发育疾病研究教育部重点实验室，儿童感染免疫重庆市重点实验室 重庆
关键词: 造血干细胞移植；肾损伤；影响因素；Hematopoietic Stem Cell Transplantation； Kidney Injury； Risk Factor
摘要: 近年来，随着医学界对造血干细胞移植(hematopoietic stem cell trans-plantation, HSCT)的研究不断加深，这种治疗方法的适应证也在不断扩大，越来越多的非肿瘤性疾病，如再生障碍性贫血、免疫缺陷和先天代谢紊乱也可以通过HSCT得到有效的治疗。化疗药物相关的肾毒性、移植物抗宿主病(GVHD)、和感染等因素，使患儿在接受造血干细胞移植后发生肾损伤的风险大大增加。而目前对于这种移植后短期或长期肾脏功能损害的研究并不完备。本文就移植后肾损伤的类型、相关危险因素以及目前的诊疗进展进行综述，期望能够对HSCT相关肾损伤的研究提供进一步的研究思路。
Abstract: In recent years, as research on hematopoietic stem cell transplantation (HSCT) has deepened within the medical community, the indications for this treatment method have expanded. Non-neoplastic diseases such as aplastic anemia, immune deficiency, and congenital metabolic disorders can now be effectively treated by HSCT. However, chemotherapy drug-related nephrotoxicity, graft-versus-host disease (GVHD), and infection increase the risk of kidney injury after HSCT. Currently, our understanding of short-term or long-term renal function impairment after transplantation is incomplete. This article reviews the types of renal injury related to HSCT, explores associated risk factors and discusses current progress in diagnosis and treatment. It aims to provide further research ideas for studying HSCT-related renal injury.
文章引用：张静茹, 窦颖. 造血干细胞移植后肾损伤的研究进展[J]. 临床医学进展, 2025, 15(5): 1603-1608. https://doi.org/10.12677/acm.2025.1551533

参考文献

[1] Renaghan, A.D., Jaimes, E.A., Malyszko, J., Perazella, M.A., Sprangers, B. and Rosner, M.H. (2019) Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation. Clinical Journal of the American Society of Nephrology, 15, 289-297. [Google Scholar] [CrossRef] [PubMed]
[2] Didsbury, M.S., Mackie, F.E. and Kennedy, S.E. (2015) A Systematic Review of Acute Kidney Injury in Pediatric Allogeneic Hematopoietic Stem Cell Recipients. Pediatric Transplantation, 19, 460-470. [Google Scholar] [CrossRef] [PubMed]
[3] Madsen, K., Pelletier, K., Côté, G., Kitchlu, A., Chen, S., Mattsson, J., et al. (2022) Acute Kidney Injury within 100 Days Post Allogeneic Hematopoietic Cell Transplantation Is Associated with Increased Risk of Post-Transplant Complications and Poor Transplant Outcomes. Bone Marrow Transplantation, 57, 1411-1420. [Google Scholar] [CrossRef] [PubMed]
[4] James, V., Angelo, J. and Elbahlawan, L. (2023) Kidney Injury in Children after Hematopoietic Stem Cell Transplant. Current Oncology, 30, 3329-3343. [Google Scholar] [CrossRef] [PubMed]
[5] Prasad, M., Jain, N.G., Radhakrishnan, J., Jin, Z. and Satwani, P. (2021) Risk Factors for Chronic Kidney Disease Following Acute Kidney Injury in Pediatric Allogeneic Hematopoietic Cell Transplantation. Bone Marrow Transplantation, 56, 1665-1673. [Google Scholar] [CrossRef] [PubMed]
[6] Hirano, D., Kakegawa, D., Miwa, S., Umeda, C., Takemasa, Y., Tokunaga, A., et al. (2020) Independent Risk Factors and Long-Term Outcomes for Acute Kidney Injury in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study. BMC Nephrology, 21, Article No. 373. [Google Scholar] [CrossRef] [PubMed]
[7] Wang, F. and Ding, J. (2020) Pediatric Acute Kidney Injury to the Subsequent CKD Transition. Kidney Diseases, 7, 10-13. [Google Scholar] [CrossRef] [PubMed]
[8] Ando, M. (2018) An Overview of Kidney Disease Following Hematopoietic Cell Transplantation. Internal Medicine, 57, 1503-1508. [Google Scholar] [CrossRef] [PubMed]
[9] Hingorani, S., Guthrie, K.A., Schoch, G., Weiss, N.S. and McDonald, G.B. (2007) Chronic Kidney Disease in Long-Term Survivors of Hematopoietic Cell Transplant. Bone Marrow Transplantation, 39, 223-229. [Google Scholar] [CrossRef] [PubMed]
[10] Wanchoo, R., Stotter, B.R., Bayer, R.L. and Jhaveri, K.D. (2019) Acute Kidney Injury in Hematopoietic Stem Cell Transplantation. Current Opinion in Critical Care, 25, 531-538. [Google Scholar] [CrossRef] [PubMed]
[11] Hingorani, S. (2016) Renal Complications of Hematopoietic-Cell Transplantation. New England Journal of Medicine, 374, 2256-2267. [Google Scholar] [CrossRef] [PubMed]
[12] Naesens, M., Kuypers, D.R.J. and Sarwal, M. (2009) Calcineurin Inhibitor Nephrotoxicity. Clinical Journal of the American Society of Nephrology, 4, 481-508. [Google Scholar] [CrossRef] [PubMed]
[13] Wanchoo, R., Bayer, R.L., Bassil, C. and Jhaveri, K.D. (2018) Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments. American Journal of Kidney Diseases, 72, 857-865. [Google Scholar] [CrossRef] [PubMed]
[14] Miyata, M., Ichikawa, K., Matsuki, E., Watanabe, M., Peltier, D. and Toubai, T. (2022) Recent Advances of Acute Kidney Injury in Hematopoietic Cell Transplantation. Frontiers in Immunology, 12, Article 779881. [Google Scholar] [CrossRef] [PubMed]
[15] Leowattana, W. (2019) Antiviral Drugs and Acute Kidney Injury (AKI). Infectious Disorders-Drug Targets, 19, 375-382. [Google Scholar] [CrossRef] [PubMed]
[16] Sakaguchi, M., Nakayama, K., Yamaguchi, H., Mii, A., Shimizu, A., Inai, K., et al. (2019) Risk Factors for Acute Kidney Injury and Chronic Kidney Disease Following Allogeneic Hematopoietic Stem Cell Transplantation for Hematopoietic Malignancies. Acta Haematologica, 143, 452-464. [Google Scholar] [CrossRef] [PubMed]
[17] 刘健, 陈志伟, 王英洁, 等. 儿童造血干细胞移植后急性肾损伤相关危险因素的回顾性研究[J]. 中国当代儿科杂志, 2022, 24(10): 1136-1142.
[18] Hingorani, S., Gooley, T., Pao, E., Sandmaier, B. and McDonald, G. (2013) Urinary Cytokines after HCT: Evidence for Renal Inflammation in the Pathogenesis of Proteinuria and Kidney Disease. Bone Marrow Transplantation, 49, 403-409. [Google Scholar] [CrossRef] [PubMed]
[19] Hingorani, S., Finn, L.S., Pao, E., Lawler, R., Schoch, G., McDonald, G.B., et al. (2015) Urinary Elafin and Kidney Injury in Hematopoietic Cell Transplant Recipients. Clinical Journal of the American Society of Nephrology, 10, 12-20. [Google Scholar] [CrossRef] [PubMed]
[20] Ho, V.T., Cutler, C., Carter, S., Martin, P., Adams, R., Horowitz, M., et al. (2005) Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 11, 571-575. [Google Scholar] [CrossRef] [PubMed]
[21] Mii, A., Shimizu, A., Yamaguchi, H. and Tsuruoka, S. (2020) Renal Complications after Hematopoietic Stem Cell Transplantation: Role of Graft-Versus-Host Disease in Renal Thrombotic Microangiopathy. Journal of Nippon Medical School, 87, 7-12. [Google Scholar] [CrossRef] [PubMed]
[22] Jodele, S., Davies, S.M., Lane, A., Khoury, J., Dandoy, C., Goebel, J., et al. (2014) Diagnostic and Risk Criteria for HSCT-Associated Thrombotic Microangiopathy: A Study in Children and Young Adults. Blood, 124, 645-653. [Google Scholar] [CrossRef] [PubMed]
[23] Musiał, K., Kałwak, K. and Zwolińska, D. (2021) The Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Kidney Function in Children—A Single Center Experience. Journal of Clinical Medicine, 10, Article 1113. [Google Scholar] [CrossRef] [PubMed]
[24] Redant, S., De Bels, D., Barbance, O., Massaut, J., Honoré, P.M., Taccone, F.S., et al. (2021) Creatinine Correction to Account for Fluid Overload in Children with Acute Respiratory Distress Syndrome Treated with Extracorporeal Membrane Oxygenation: An Initial Exploratory Report. Pediatric Nephrology, 37, 891-898. [Google Scholar] [CrossRef] [PubMed]
[25] Benoit, S.W., Dixon, B.P., Goldstein, S.L., Bennett, M.R., Lane, A., Lounder, D.T., et al. (2019) A Novel Strategy for Identifying Early Acute Kidney Injury in Pediatric Hematopoietic Stem Cell Transplantation. Bone Marrow Transplantation, 54, 1453-1461. [Google Scholar] [CrossRef] [PubMed]
[26] Tibúrcio, F.R., Rodrigues, K.E.d.S., Belisário, A.R. and Simões-e-Silva, A.C. (2018) Glomerular Hyperfiltration and β-2 Microglobulin as Biomarkers of Incipient Renal Dysfunction in Cancer Survivors. Future Science OA, 4, FSO333. [Google Scholar] [CrossRef] [PubMed]
[27] Jodele, S., Laskin, B.L., Dandoy, C.E., Myers, K.C., El-Bietar, J., Davies, S.M., et al. (2015) A New Paradigm: Diagnosis and Management of HSCT-Associated Thrombotic Microangiopathy as Multi-System Endothelial Injury. Blood Reviews, 29, 191-204. [Google Scholar] [CrossRef] [PubMed]
[28] Sartain, S., Shubert, S., Wu, M., Srivaths, P., Teruya, J., Krance, R., et al. (2019) Therapeutic Plasma Exchange Does Not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience. Biology of Blood and Marrow Transplantation, 25, 157-162. [Google Scholar] [CrossRef] [PubMed]
[29] Jodele, S., Fukuda, T., Vinks, A., Mizuno, K., Laskin, B.L., Goebel, J., et al. (2014) Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy. Biology of Blood and Marrow Transplantation, 20, 518-525. [Google Scholar] [CrossRef] [PubMed]
[30] Jodele, S., Dandoy, C.E., Lane, A., Laskin, B.L., Teusink-Cross, A., Myers, K.C., et al. (2020) Complement Blockade for TA-TMA: Lessons Learned from Large Pediatric Cohort Treated with Eculizumab. Blood, 135, 1049-1057. [Google Scholar] [CrossRef] [PubMed]

为你推荐